Isoform-specific inhibition of RORα-mediated transcriptional activation by human FOXP3

Journal of Immunology

Volumn 180, Issue 7, 2008, Pages 4785-4792

  Du, Jianguang ^a,c   Huang, Chunjian ^a   Zhou, Baohua ^a   Ziegler, Steven F ^a,b  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR RELATED ORPHAN RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; CELL RECEPTOR; FACTOR AF2; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; RAR RELATED ORPHAN RECEPTOR A; RAR-RELATED ORPHAN RECEPTOR A; TISSUE EXTRACT; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA BINDING; EXON; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; TH17 CELL; TRANSCRIPTION INITIATION; CELL LINE; GENETICS; METABOLISM; PROTEIN BINDING; TRANSACTIVATION;

AMINO ACID MOTIFS; CELL LINE; EXONS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TISSUE EXTRACTS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

EID: 44449131480     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.7.4785     Document Type: Article

References (45)

1. Shevach, E. M. 2000. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18: 423-449.
2. Itoh, M., T. Takahashi, N. Sakaguchi, Y. Kuniyasu, J. Shimizu, F. Otsuka, and S. Sakaguchi. 1999. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162: 5317-5326.
3. Baecher-Allan, C., V. Viglietta, and D. A. Hafler. 2004. Human CD4+CD25+ regulatory T cells. Semin. Immunol. 16: 89-98.
4. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182: 18-32.
5. Jordan, M. S., A. Boesteanu, A. J. Reed, A. L. Petrone, A. E. Holenbeck, M. A. Lerman, A. Maji, and A. J. Caton. 2001. Thymic selection of CD4+CD25 + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2: 301-306.
6. Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adapted regulatory T cells. Nat. Rev. Immunol. 3: 253-257.
7. + regulatory T cells. Nat. Immunol. 4:330-336.
8. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor FoxP3. Science 299: 1057-1061.
9. Khattri, R., T. Cox, S.-A. Yasayko, and F. Ramsdell. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4: 337-342.
10. Wildin, R. S., F. Ramsdell, J. Peake, F. Faravelli, J.-L. Casanova, N. Buist, E. Levy-Lahad, M. Mazzella, O. Goulet, L. Perroni, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27: 18-20.
11. Bennett, C. L., J. Christie, F. Ramsdell, M. E. Brunkow, P. F. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance, and H. D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutation of FOXP3. Nat. Genet. 27: 20-21.
12. Chatila, T. A., F. Blaeser, N. Ho, H. M. Lederman, C. Voulgaropoulos, C. Helms, and A. M. Bowcock. 2000. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106:R75-R81.
13. - T cells. J. Clin. Invest. 112: 1437-1443.
14. + T regulatory cells in humans. Hum. Immunol. 66: 13-20.
15. + T regulatory cells. J. Clin. Invest. 115: 3276-3284.
16. Jetten, A. M., and E. Ueda. 2002. Retinoid-related orphan receptors (RORs): roles in cell survival, differentiation, and disease. Cell Death Differ. 9: 1167-1171.
17. Delerive, P., D. Monte, G. Dubois, F. Trottein, J. Fruchart-Najib, J. Mariani, J. Fruchart, and B. Staels. 2001. The orphan nuclear receptor ROR is a negative regulator of the inflammatory response. EMBO Rep. 21: 42-48.
18. Dzhagalov, I., V. Giguere, and Y. He. 2004. Lymphocyte development and function in the absence of retinoic acid-related orphan receptor. J. Immunol. 173: 2952-2959.
19. Andre, E., F. Conquet, M. Steinmayr, S. C. Stratton, V. Porciatti, and M. Becker-Andre. 1998. Disruption of retinoid-related orphan receptor changes circadian behavior, causes retinal degeneration, and leads to vacillans phenotype in mice. EMBO J. 17: 3867-3877.
20. Sun, Z., D. Unutmaz, Y. R. Zou, M. J. Sunshine, A. Pierani, S. Brenner-Morton, R. E. Mebius, and D. R. Littman. 2000. Requirement for RORγ in thymocyte survival and lymphoid organ development. Science 288: 2369-2373.
21. Kuribayashi, S., E. Ueda, M. Sakaue, D. D. Patel, A. Medvedev, F. Zhang, and A. M. Jetten. 2000. Retinoid-related orphan receptor y (RORγ) is essential for lymphoid organogenesis and control apoptosis during thymopoiesis. Proc. Natl. Acad. Sci. USA 97: 10132-10137.
22. Eberl, G., S. Marmon, M. J. Sunshine, P. D. Rennert, Y. Choi, and D. R. Littman. 2004. An essential function for the nuclear receptor RORyt in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5: 64-73.
23. Lee, H. C., and S. F. Ziegler. 2007. Inducible expression of the proallergic cy-tokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NF-κB.Proc. Natl. Acad. Sci. USA 104: 914-919.
24. Lopes, J. E., T. R. Torgerson, L. A. Schubert, S. D. Anover, E. L. Ocheltree, H. D. Ochs, and S. F. Ziegler. 2006. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J. Immunol. 177: 3133-3142.
25. Migita, H., N. Satozawa, J. Lin, J. Morser, and K. Kawai. 2004. RORα1 and RORα4 suppress TNF-induced VCAM-1 and ICAM-1 expression in human endothelial cells. FEBS Lett. 557: 269-274.
26. Jetten, A. M., K. Kuribayashi, and E. Ueda. 2001. The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes. Prog. Nucleic Acid Res. Mol. Biol. 69: 205-247.
27. Schubert, L. A., E. W. Jeffery, Y. Zhang, F. Ramsdell, and S. F. Ziegler. 2001. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276: 37672-37679.
28. Li, Y., M. H. Lambert, and J. E. Xu. 2003. Activation of nuclear receptors: a perspective from structural genomics. Structure 11: 741-746.
29. Henttu, P. M. A., E. Kalkhoven, and M. G. Parker. 1997. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol. Cell. Biol. 17: 1832-1839.
30. Atkins, G. B., X. Hu, M. G. Guenther, C. Rachez, L. P. Freedman, and M. A. Lazar. 1999. Coactivators for the orphan nuclear receptor RORα. Mol. Endocrinol. 13: 1550-1557.
31. Harris, J. M., P. Lau, S. L. Chen, and G. E. O. Muscat. 2002. Characterization of the retinoid orphan-related receptor-α coactivator binding interface: a structural basis for ligand-independent transcription. Mol. Endocrinol. 16: 998-1012.
32. Darimont, B. D., R. L. Wagner, J. W. Apriletti, M. R. Stallcup, P. J. Kushner, J. D. Baxter, R. J. Fletterick, and K. R. Yamamoto. 1998. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12: 3343-3356.
33. Godfrey, V., J. E. Wilkinson, and L. B. Russell. 1991. X-linked lymphoreticular disease in the scrufy (sf) mutant mouse. Am. J. Pathol. 138: 1379-1387.
34. Torgerson, T. R., and H. D. Ochs. 2002. Immune dysregulation, polyendocri-nopathy, enteropathy, X-linked syndrome: a model of immune dysregulation. Curr. Opin. Allergy Clin. Immunol. 2: 481-487.
35. + regulatory T cells. Int. Immunol. 16: 1643-1656.
36. Chae, W.-J., O. Henegariu, S.-K. Lee, and A. L. M. Bothwell. 2006. The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells. Proc. Natl. Acad. Sci. USA 103: 9631-9636.
37. Bettelli, E., M. Dastrange, and M. Oukka. 2005. Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA 102: 5138-5143. 38. Wu, Y., M. Borde, V. Heissmeyer, M. Feuerer, A. D. Lapan, J. C. Stroud, D. L. Bates, L. Guo, A. Han, S. F. Ziegler, et al. 2006. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126: 375-387.
38. Kobayashi, I., R. Shiari, M. Yamada, N. Kawamura, M. Okano, A. Yara, A. Iguchi, N. Ishidawa, T. Ariga, Y. Sakiyama, et al. 2001. Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). J. Med. Genet. 38: 874-876.
39. Feng, W., R. C. J. Ribeiro, R. L. Wagner, H. Nguyen, J. W. Apriletti, R. J. Fletterick, J. D. Baxter, P. J. Kushner, and B. L. West. 1998. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280: 1747-1749.
40. Hu, X., and M. A. Lazar. 1999. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402: 93-96.
41. Nagy, L., H. Y. Kao, J. D. Love, C. Li, E. Banayo, J. T. Gooch, V. Krishna, K. Chatterjee, R. M. Evans, and J. W. Schwabe. 1999. Mechanisms of corepres-sor binding and release from nuclear hormone receptors. Genes Dev. 13: 3209-3216.
42. Perissi, V., L. M. Stazewski, E. M. McInerney, R. Kurokawa, A. Krones, D. W. Rose, M. H. Lambert, M. V. Milburn, C. K. Glass, and M. G. Rosenfeld. 1999. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13: 3198-3208.
43. Heery, D. M., E. Kalkhoven, S. Hoare, and M. G. Parker. 1997. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387: 733-737.
44. + T helper cells. Cell 126: 1121-1133.
45. Matysiak-Scholze, U., and M. Nehls. 1997. The structural integrity of ROR iso-forms is mutated in staggerer mice: cerebellar coexpression of ROR1 and ROR4. Genomics 43: 78-84.